Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG; Journal Of The National Cancer Institute, 1997, vol. 89, issue 22, p 1673, ISSN 00278874. ISBN 00278874.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef